HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial.

AbstractBACKGROUND & AIMS:
Gastric variceal bleeding is severe and is associated with high mortality. We compared the efficacy of cyanoacrylate injection and beta-blockers in primary prophylaxis of gastric variceal bleeding.
METHODS:
Cirrhotics with large gastroesophageal varices type 2 with eradicated esophageal varices or large isolated gastric varix type 1, who had never bled from gastric varix, were randomised to cyanoacrylate injection (Group I, n=30), beta-blockers (Group II, n=29) or no treatment (Group III, n=30). Primary end-points were bleeding from gastric varix or death.
RESULTS:
The actuarial probability of bleeding from gastric varices over a median follow-up of 26 months was 13% in Group I, 28% in Group II (p=0.039), and 45% in Group III (p=0.003). The actuarial probability of survival was higher in the cyanoacrylate compared to the no-treatment group (90% vs. 72%, p=0.048). The median hepatic venous pressure gradient (HVPG) was increased in Group I (14-15 mm Hg, p=0.001) and III (14-16 mm Hg, p=0.001) but decreased in Group II (14 to 12 mm Hg, p=0.001) during follow-up. Size of gastric varix >20 mm, a MELD score ≥17, and presence of portal hypertensive gastropathy predicted 'high risk' of first bleeding from gastric varices.
CONCLUSIONS:
Primary prophylaxis is recommended in patients with large and high risk gastric varices to reduce the risk of first bleeding and mortality. Cyanoacrylate injection is more effective than beta-blocker therapy in preventing first gastric variceal bleeding.
AuthorsSmruti Ranjan Mishra, Barjesh Chander Sharma, Ashish Kumar, Shiv Kumar Sarin
JournalJournal of hepatology (J Hepatol) Vol. 54 Issue 6 Pg. 1161-7 (Jun 2011) ISSN: 1600-0641 [Electronic] Netherlands
PMID21145834 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Adrenergic beta-Antagonists
  • Cyanoacrylates
  • Propranolol
Topics
  • Adolescent
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Aged
  • Child
  • Cyanoacrylates (administration & dosage)
  • Esophageal and Gastric Varices (drug therapy, pathology, physiopathology)
  • Female
  • Gastrointestinal Hemorrhage (prevention & control)
  • Humans
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Propranolol (therapeutic use)
  • Venous Pressure
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: